Zorubicin
Zorubicin[edit]
Zorubicin is an anthracycline antibiotic that is used in the treatment of various types of cancer. It is a chemotherapy agent that works by intercalating DNA, thereby inhibiting the synthesis of nucleic acids and inducing apoptosis in rapidly dividing tumor cells.
Mechanism of Action[edit]
Zorubicin functions primarily by intercalating between DNA base pairs, disrupting the DNA replication process. This intercalation prevents the enzyme topoisomerase II from resealing the DNA double helix, leading to DNA strand breaks. The accumulation of these breaks triggers cell death pathways, particularly apoptosis.
Clinical Use[edit]
Zorubicin is used in the treatment of several types of cancer, including breast cancer, lung cancer, and lymphoma. It is often administered as part of a chemotherapy regimen in combination with other anticancer drugs.
Administration[edit]
Zorubicin is typically administered intravenously. The dosage and schedule depend on the type of cancer being treated, the patient's overall health, and other factors such as kidney function and liver function.
Side Effects[edit]
Common side effects of Zorubicin include nausea, vomiting, hair loss, and myelosuppression, which is a decrease in the production of blood cells. More serious side effects can include cardiotoxicity, which is damage to the heart muscle, and secondary leukemia.
Pharmacokinetics[edit]
Zorubicin is metabolized in the liver and excreted primarily in the bile. It has a relatively short half-life, which necessitates frequent dosing to maintain therapeutic levels.
